FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056580837> ?p ?o ?g. }

• W2056580837 endingPage "772" @default.
• W2056580837 startingPage "763" @default.
• W2056580837 abstract "The activation of endothelial cells is a recurrent phenomenon linked to pathologic conditions such as inflammation, chronic arthritis, allo- and xenograft rejection. To inhibit endothelial cell activation we have constructed a transactivation-deficient derivative of the p65/RelA subunit of NF-kappa B, a transcription factor known to be crucial for the induction of adhesion molecules, cytokines and procoagulants in activated endothelial cells. This protein (p65RHD) comprises the Rel homology domain of the RelA subunit, retaining dimerization, DNA binding, and nuclear localization functions, but is deficient in transcriptional activation, and acts as a competitive inhibitor of NF-kappa B. Our data demonstrate that p65RHD is a potent and specific inhibitor of NF-kappa B-mediated induction of a number of genes, such as I kappa B alpha, IL-8, E-selectin, P-selectin, and tissue factor in endothelial cells. Furthermore, tetracycline-inducible expression of p65RHD in stably transfected primary endothelial cells inhibits the induction of gene expression equally well. This regulated system of gene expression provides the basis for a novel therapeutic approach to the pathologic effects of endothelial cell activation, especially in delayed xenograft rejection, by using transgenic animals as organ donors." @default.
• W2056580837 created "2016-06-24" @default.
• W2056580837 creator A5020061215 @default.
• W2056580837 creator A5050787140 @default.
• W2056580837 creator A5058899441 @default.
• W2056580837 creator A5064929406 @default.
• W2056580837 creator A5067643807 @default.
• W2056580837 creator A5088991914 @default.
• W2056580837 date "1997-02-15" @default.
• W2056580837 modified "2023-09-25" @default.
• W2056580837 title "Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B." @default.
• W2056580837 cites W14378625 @default.
• W2056580837 cites W1485904813 @default.
• W2056580837 cites W1503524848 @default.
• W2056580837 cites W1509979785 @default.
• W2056580837 cites W1522999898 @default.
• W2056580837 cites W1529651253 @default.
• W2056580837 cites W1540687523 @default.
• W2056580837 cites W1562330095 @default.
• W2056580837 cites W1564274931 @default.
• W2056580837 cites W1584944565 @default.
• W2056580837 cites W1769783081 @default.
• W2056580837 cites W1771892390 @default.
• W2056580837 cites W1825540737 @default.
• W2056580837 cites W1826524642 @default.
• W2056580837 cites W1887677860 @default.
• W2056580837 cites W1904705252 @default.
• W2056580837 cites W1920787626 @default.
• W2056580837 cites W1934086060 @default.
• W2056580837 cites W1970507145 @default.
• W2056580837 cites W197598342 @default.
• W2056580837 cites W1978993962 @default.
• W2056580837 cites W1980166683 @default.
• W2056580837 cites W1980225083 @default.
• W2056580837 cites W1982062664 @default.
• W2056580837 cites W1990698300 @default.
• W2056580837 cites W1991928333 @default.
• W2056580837 cites W2002601205 @default.
• W2056580837 cites W2005275397 @default.
• W2056580837 cites W2008494281 @default.
• W2056580837 cites W2009296843 @default.
• W2056580837 cites W2010285561 @default.
• W2056580837 cites W2018204952 @default.
• W2056580837 cites W2023105368 @default.
• W2056580837 cites W2029276835 @default.
• W2056580837 cites W2031585752 @default.
• W2056580837 cites W2036770241 @default.
• W2056580837 cites W2056945702 @default.
• W2056580837 cites W2057093252 @default.
• W2056580837 cites W2058971952 @default.
• W2056580837 cites W2062205148 @default.
• W2056580837 cites W2063500485 @default.
• W2056580837 cites W2065422942 @default.
• W2056580837 cites W2065519715 @default.
• W2056580837 cites W2070853191 @default.
• W2056580837 cites W2074011532 @default.
• W2056580837 cites W2074069338 @default.
• W2056580837 cites W2083230754 @default.
• W2056580837 cites W2083569066 @default.
• W2056580837 cites W2083809000 @default.
• W2056580837 cites W2088555845 @default.
• W2056580837 cites W2089478514 @default.
• W2056580837 cites W2090429649 @default.
• W2056580837 cites W2097794242 @default.
• W2056580837 cites W2108526355 @default.
• W2056580837 cites W2109478329 @default.
• W2056580837 cites W2112360090 @default.
• W2056580837 cites W2116650665 @default.
• W2056580837 cites W2122559781 @default.
• W2056580837 cites W2148110596 @default.
• W2056580837 cites W2150033965 @default.
• W2056580837 cites W2155629196 @default.
• W2056580837 cites W2158708535 @default.
• W2056580837 cites W2164925666 @default.
• W2056580837 cites W2168592519 @default.
• W2056580837 cites W2169053713 @default.
• W2056580837 cites W2419332336 @default.
• W2056580837 cites W3210418 @default.
• W2056580837 cites W37351408 @default.
• W2056580837 cites W7532581 @default.
• W2056580837 cites W75708282 @default.
• W2056580837 cites W95988660 @default.
• W2056580837 doi "https://doi.org/10.1172/jci119222" @default.
• W2056580837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/507861" @default.
• W2056580837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9045881" @default.
• W2056580837 hasPublicationYear "1997" @default.
• W2056580837 type Work @default.
• W2056580837 sameAs 2056580837 @default.
• W2056580837 citedByCount "78" @default.
• W2056580837 countsByYear W20565808372012 @default.
• W2056580837 countsByYear W20565808372013 @default.
• W2056580837 countsByYear W20565808372014 @default.
• W2056580837 countsByYear W20565808372015 @default.
• W2056580837 countsByYear W20565808372020 @default.
• W2056580837 crossrefType "journal-article" @default.
• W2056580837 hasAuthorship W2056580837A5020061215 @default.
• W2056580837 hasAuthorship W2056580837A5050787140 @default.
• W2056580837 hasAuthorship W2056580837A5058899441 @default.

• next